Text Size

Autoantibodies and Clinical Symptoms in Infective Endocarditis Patients

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2007 by Tel-Aviv Sourasky Medical Center.
Recruitment status was  Not yet recruiting
Sponsor:
Collaborator:
Ministry of Health, Israel
Information provided by:
Tel-Aviv Sourasky Medical Center
ClinicalTrials.gov Identifier:
NCT00562653
First received: November 20, 2007
Last updated: November 21, 2007
Last verified: November 2007
History of Changes
  Purpose

The purpose is to evaluate autoantibodies in infective endocarditis patients before, at the beginning of treatment, and after the end of the treatment, and to correlate the autoantibodies in the presence of clinical symptoms.


Condition
Infective Endocarditis

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Study of Autoantibodies in Infective Endocarditis

Resource links provided by NLM:

MedlinePlus related topics: Endocarditis
U.S. FDA Resources

Further study details as provided by Tel-Aviv Sourasky Medical Center:

Biospecimen Retention:   None Retained

serum


Estimated Enrollment: 100
Study Start Date: November 2007
Estimated Study Completion Date: November 2008
Groups/Cohorts
1
infective endocarditis patients before treatment
2
infective endocarditis treatment after treatment
3
control

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

infective endocarditis patients

Criteria

Inclusion Criteria:

  • Infective endocarditis patients by DUKES criteria

Exclusion Criteria:

  • HIV positive
  • Patients suffering from other infective diseases other than endocarditis.
  • Patient suffering from collagen diseases for example: systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), mixed connective tissue disease, and scleroderma.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00562653

Locations
Israel
Sourasky Medical Center Not yet recruiting
Tel-Aviv, Israel
Sponsors and Collaborators
Tel-Aviv Sourasky Medical Center
Ministry of Health, Israel
Investigators
Principal Investigator: Victoria Bogusllavsky, MD Sourasky Medical Center, Internal Medicine
  More Information

Additional Information:
medical internet site  This link exits the ClinicalTrials.gov site

No publications provided

ClinicalTrials.gov Identifier: NCT00562653     History of Changes
Other Study ID Numbers: sourasky medical centrs
Study First Received: November 20, 2007
Last Updated: November 21, 2007
Health Authority: Israel: Ministry of Health

Keywords provided by Tel-Aviv Sourasky Medical Center:
profile autoantibodies
clinical symptoms

Additional relevant MeSH terms:
Endocarditis
Endocarditis, Bacterial
Heart Diseases
Cardiovascular Diseases
Bacterial Infections
Cardiovascular Infections
 Infection
Autoantibodies
Immunologic Factors
Physiological Effects of Drugs
Pharmacologic Actions

ClinicalTrials.gov processed this record on May 23, 2013